Latest Regulatory Approvals News

Clarity Pharmaceuticals has successfully imaged the first patient in its pivotal Phase III AMPLIFY trial for Cu-SAR-bisPSMA, a next-generation diagnostic agent targeting recurrent prostate cancer. This milestone sets the stage for potential FDA approval and broader clinical adoption.

Agrimin Limited has initiated a strategic review of its flagship Mackay Potash Project following prolonged approvals and market challenges, while spotlighting its valuable stakes in WA1 Resources and an upcoming Tali Resources IPO.

Felix Gold Limited has confirmed its ability to produce premium-grade antimony concentrate with up to 69% purity from its Treasure Creek Project in Alaska, targeting production by late 2025. The results align with U.S. strategic mineral priorities amid a tightening global supply.

Red Sky Energy has partnered with Condor Energy and associates to fund the drilling of the KN2 well at Killanoola, targeting a promising new reservoir zone identified by advanced seismic data. This move aims to boost production and accelerate cash flow from the South Australian oil project.

Estrella Resources has initiated Timor-Leste’s inaugural modern metallic minerals drilling campaign, targeting manganese at the Ira Miri Prospect. This milestone marks a new chapter in the country’s mineral exploration history.

Aroa Biosurgery has reported FY25 results that exceed revenue guidance and deliver a positive normalised EBITDA, setting the stage for ambitious growth and reimbursement expansion in FY26.

Hot Chili Limited has identified multiple new porphyry copper-gold targets adjacent to its La Verde discovery in Chile, signaling a potential district-scale mineral system. The company plans to advance exploration with phase-two drilling targeting these promising blind deposits.

Avecho Biotechnology has received $1.66 million from the Australian Government’s R&D Tax Incentive, reinforcing its commitment to a pivotal Phase III trial for its CBD-based insomnia treatment and accelerating its commercial ambitions.

ReNerve Limited has gained marketing approval for its NervAlign® Nerve Cuff™ in Bahrain, marking its first regulatory success in the Middle East and opening access to a rapidly expanding regional market.

Epsilon Healthcare has emerged from Administration, securing expanded medicinal cannabis manufacturing permits and launching a new pharmacy brand as part of a strategic turnaround and growth plan.

Titanium Sands Limited has secured one-year retentions for four high-grade exploration licenses, enabling critical environmental studies and paving the way for a mining license application in Sri Lanka.

Copper Search Ltd has successfully raised $850,000 through a placement and announced a subsequent $504,364 rights issue to fund exploration targeting Heavy Mineral Sands in South Australia and gold-copper prospects in New South Wales.